| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a65c632a0dd973ba35958d1be29f4c1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_771ff8fd8b4d2ed18c11d77cfb0d4155 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2009-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a13a3950a19826efe9eaf0dfad56c609
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e57d449a158073ec4a163fb5108a704 |
| publicationDate |
2009-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009263334-A1 |
| titleOfInvention |
Cyclic Glycyl-2-Allyl Proline Improves Cognitive Performance in Impaired Animals |
| abstract |
Embodiments of this invention provide methods for therapeutic use of cyclic G-2-Allyl Proline to treat cognitive disorders as well as manufacture of medicaments including tablets, capsules, injectable solutions that are useful for treatment of such conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2468813-C1 |
| priorityDate |
2006-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |